TB
Tolerance Bio Inc.
SEC filingBiotechnology · Philadelphia, PA
Amount raised$15.1Msold at filing
Total offeringNot stated
Investors in the raise13count reported to the SEC
FiledJun 18, 2026first sale Jun 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Philip Tormo BallExecutive Officer, Director
Damia Tormo CarullaDirector
Justin VogelExecutive Officer, Director
Francisco LeonExecutive Officer, Director
Pablo Tormo CironiDirector
Robert Tormo GoldsteinDirector
Executive officers, directors and promoters as listed on the Form D.